Cancer diagnostic services in the country encompass pathology, laboratory medicine, diagnostic imaging, and interventional radiology specialties. Challenges in these areas contribute to delayed cancer diagnoses, with 70% of cases identified in late stages. The strategy proposed involves strengthening diagnostic services according to established standards, providing necessary infrastructure, capacity building for primary care providers, and optimizing diagnostic networks through the use of the latest technology and digital tools. The establishment of the National Cancer Reference Laboratory (NCRL) aims to lead in timely specialized tests, expand diagnostic networks, ensure quality assurance, and provide technical support. However, challenges in genomic testing availability persist, and efforts are needed to enhance access to these services within the country. Additionally, investments in radiology infrastructure and equipment have been made, but addressing quality assurance and human resource limitations is crucial to maximizing the utilization of diagnostic imaging and interventional services. The strategy seeks to collaborate with stakeholders to bridge these gaps and expand access to comprehensive cancer diagnostic services.